Heidelberg Epignostix
Heidelberg Epignostix develops and markets software solutions for molecular tumor classification using DNA methylation profiling and machine learning. The company provides specific diagnostic tools including a CNS tumor methylation classifier and a sarcoma methylation classifier to assist pathology and healthcare professionals. Their technology aims to improve diagnostic accuracy and personalize treatment management for cancer patients.
Visit websiteHeidelberg, Germany
Healthtech
Oncology
Bioinformatics
Diagnostics
Funding summary
- Total raised
- €4.3M
- Funding rounds
- 1
Investors in Heidelberg Epignostix
Investors on record for Heidelberg Epignostix. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Heidelberg Epignostix?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors